Should my family or I have genetic testing?

 

Q: Should my family or I have genetic testing? 

A: You can inherit a higher risk of developing certain cancers. Yet only about 5 to 10 percent of cancers are inherited. Depending upon the type of cancer you have, there may be a screening test that can determine if you carry a genetic mutation that puts you and your close blood relatives at higher risk. 

Genetic testing for cancer risk is still largely in its scientific infancy. Finding a genetic mutation in a test does not mean that person will definitely develop cancer. Discuss the possibility of genetics playing a role in your cancer with your doctor. If  indicated, your doctor will refer you to a genetic counselor to learn about the risks, limitations, and benefits of genetic testing.
--Kathy Newman, RN, BSN

See the benefits and risks of genetic testing.

Latest Cancer News
Urinary Prostate Cancer Test, PCA3, Predictive of Biopsy Outcomes

March 9, 2010 — Researchers involved in the international Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial have reported that the urinary PCA3 test can predict biopsy outcome in men taking dutasteride. The details of two studies were presented at the 2010 American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposium held in San Francisco, March 5-7.

HPV Vaccine Provides Little Benefit for Older Women

March 9, 2010 — Researchers from Costa Rica have reported that women over the age of 40 are not likely to benefit from vaccination to prevent human papillomavirus (HPV). The details of this study were published in the March 3, 2010 issue of the Journal of the National Cancer Institute.

Oncotype DX® Predicts Recurrence Risk in Node-negative and Node-positive Breast Cancer Treated with Tamoxifen or Arimidex

March 9, 2010 — Among postmenopausal women with early, hormone receptor-positive breast cancer treated with either tamoxifen (Nolvadex®) or Arimidex® (anastrozole), the Oncotype DX test predicts the risk of distant cancer recurrence in both node-negative and node-positive patients. These results were published in the Journal of Clinical Oncology.

Select news items provided by Reuters Health